Hyponatremia
📧 Sign up to get email alerts when something new happens for Hyponatremia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of SR121463B in patients with Syndrome of inappropriate antidiuretic hormone secre…
-
CLINICAL_TRIALS trial_result · 2008-12-10Clinical Trial Update: Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [Phase 3]
Phase 3 trial evaluating the efficacy and safety of SR121463B in patients with syndrome of inappropriate antidiuretic hormone secretion (SIA…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [Phase 2]
Phase 2 trial evaluating the efficacy of SR121463B in Syndrome of inappropriate antidiuretic hormone secretion and hyponatremia has complete…
-
EMA withdrawal · 2008-05-28EMA Application withdrawn: Aquilda (satavaptan) — Sanofi-Aventis
The EMA withdrew the application for Aquilda (satavaptan) by Sanofi-Aventis for the treatment of hyponatremia.
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Management of Hyponatremia in Preterm Infants on Diuretics [Phase 3]
A Phase 3 clinical trial evaluating management of hyponatremia in preterm infants on diuretics has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: "SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia [Phase 3]
The SALT trial, a Phase 3 study evaluating escalating doses of tolvaptan for hyponatremia, has completed.